These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29755223)

  • 21. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: A randomized control trial.
    Nidhi R; Padmalatha V; Nagarathna R; Amritanshu R
    Int J Yoga; 2012 Jul; 5(2):112-7. PubMed ID: 22869994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome.
    Murphy MK; Hall JE; Adams JM; Lee H; Welt CK
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3878-84. PubMed ID: 16882750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep Duration, Exercise, Shift Work and Polycystic Ovarian Syndrome-Related Outcomes in a Healthy Population: A Cross-Sectional Study.
    Lim AJ; Huang Z; Chua SE; Kramer MS; Yong EL
    PLoS One; 2016; 11(11):e0167048. PubMed ID: 27870902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian Syndrome.
    Abbara A; Eng PC; Phylactou M; Clarke SA; Hunjan T; Roberts R; Vimalesvaran S; Christopoulos G; Islam R; Purugganan K; Comninos AN; Trew GH; Salim R; Hramyka A; Owens L; Kelsey T; Dhillo WS
    Front Endocrinol (Lausanne); 2019; 10():656. PubMed ID: 31616381
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of pilates on regulating menstrual cycle in females with polycystic ovarian syndrome.
    Nazir S; Sadhu S
    Eur J Obstet Gynecol Reprod Biol X; 2024 Mar; 21():100271. PubMed ID: 38179109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
    Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
    J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity, rather than menstrual cycle pattern or follicle cohort size, determines hyperinsulinaemia, dyslipidaemia and hypertension in ageing women with polycystic ovary syndrome.
    Elting MW; Korsen TJ; Schoemaker J
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):767-76. PubMed ID: 11895219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality of life and its relationship with clinical symptoms among Iranian patients with polycystic ovarian syndrome.
    Bazarganipour F; Ziaei S; Montazeri A; Foroozanfard F; Faghihzadeh S
    Iran J Reprod Med; 2013 May; 11(5):371-8. PubMed ID: 24639768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystic Ovary Syndrome among Obese Adolescents.
    Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
    Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of polycystic ovary syndrome in childhood and adolescence.
    Ojaniemi M; Tapanainen P; Morin-Papunen L
    Horm Res Paediatr; 2010; 74(5):372-5. PubMed ID: 20861609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence.
    Ibáñez L; Oberfield SE; Witchel S; Auchus RJ; Chang RJ; Codner E; Dabadghao P; Darendeliler F; Elbarbary NS; Gambineri A; Garcia Rudaz C; Hoeger KM; López-Bermejo A; Ong K; Peña AS; Reinehr T; Santoro N; Tena-Sempere M; Tao R; Yildiz BO; Alkhayyat H; Deeb A; Joel D; Horikawa R; de Zegher F; Lee PA
    Horm Res Paediatr; 2017; 88(6):371-395. PubMed ID: 29156452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls--a 2 year follow-up study.
    Nair MK; Pappachan P; Balakrishnan S; Leena ML; George B; Russell PS
    Indian J Pediatr; 2012 Jan; 79 Suppl 1():S69-73. PubMed ID: 21769526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature.
    Azziz R
    J Clin Endocrinol Metab; 2006 Mar; 91(3):781-5. PubMed ID: 16418211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovaries and associated clinical and biochemical features among women with infertility in a tertiary hospital in Tanzania.
    Pembe AB; Abeid MS
    Tanzan J Health Res; 2009 Oct; 11(4):175-80. PubMed ID: 20734696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.